The independent source for health policy research, polling, and news.
Showing 101 - 118 of 118
Data and safety monitoring boards work under a cloak of secrecy meant to prevent undue influence by stakeholders, such as companies or the government. In the Trump era, some worry the anonymity could actually invite it.
While insulin is the poster child for outrageous prescription costs, patients are paying ever more to treat depression, asthma, HIV, cholesterol and more. And the pandemic has overtaken efforts to force the issue in Congress.
A KHN review found more than 20 states either don’t count or have incomplete data on the use of COVID-19 antigen tests, leaving the public in the dark about the true scope of the pandemic.
Experts say the administration’s approach with antigen tests could add cost and risk for the most vulnerable patients.
State officials said they urgently needed millions more masks and gowns, internal emails show. At least 80 Georgia health workers have died from COVID-19, including after the state reopened its economy.
Half of the money the Trump administration gave dialysis companies was collected by Fresenius, an international juggernaut with a robust balance sheet, a KHN analysis has found.
After the FDA issues a public warning about the test, one of its senior officials says point-of-care coronavirus tests can miss 20% of cases and still be considered useful. Public health experts are split.
Although laws prohibit price gouging on precious resources in times of emergency, states have been forced to compete for a share of the nation’s stockpile of ventilators — used to treat the sickest COVID patients — or pay top dollar on sideline deals. With quality and quantity control lacking, what happens when the pandemic’s second wave hits?
At least half of the top 10 recipients, part of a group that received $20 billion in emergency HHS funding, have paid criminal penalties or settled charges related to improper billing and other practices.
HHS said this test would “save personal protective equipment.” But Abbott’s very design ― devised for mobile testing — means those working with specimens need even more protection, experts warn.
Despite intense lobbying for a piece of the $100 billion bailout pot, big New York hospitals and rural systems alike say they aren’t getting a fair share.
States urgently need millions of tests, and the game changer they’ve been waiting on falls well short of what is needed, according to government documents obtained by KHN.
As President Donald Trump called the nation “in good shape” to handle COVID-19, a cache of emails released by officials in Washington state show that top public health authorities feared gear shortages and doctor safety in the early epicenter of sickness and deaths.
The Centers for Disease Control and Prevention gave huge cities roughly the same number of test kits as some rural spots, which crippled efforts by health officials to contain the virus.
For those who are sexually active, condoms are widely recognized as the most effective method for preventing HIV and other diseases, if used correctly. But a fact sheet with “unapproved condom imagery” was taken down from a federal website, KHN has learned.
As lawmakers consider bills to protect patients against surprise medical bills, doctors have waged a stealth on-the-ground campaign to win over members of Congress. Here’s how they did it.
Federal officials unveiled guidance for states that want to opt out of some of the current funding program and instead seek a fixed payment to gain more flexibility.
The president, who has repeatedly pledged to improve health care and lower prescription drug prices, faces disapproval from a majority of Americans on his policies regarding drug costs, protecting people with preexisting conditions and the Affordable Care Act.
Stay informed by signing up for the Morning Briefing and other emails:
© 2026 KFF